216 related articles for article (PubMed ID: 21470864)
1. Semisynthesis of triptolide analogues: effect of γ-lactone and C-14 substituents on cytotoxic activities.
Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
Bioorg Med Chem Lett; 2011 May; 21(10):3046-9. PubMed ID: 21470864
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of novel D-ring-modified triptolide analogues: structure-cytotoxic activity relationship studies on the D-ring of triptolide.
Zhou B; Li X; Tang H; Miao Z; Feng H; Li Y
Org Biomol Chem; 2011 May; 9(9):3176-9. PubMed ID: 21409265
[TBL] [Abstract][Full Text] [Related]
3. Semisynthesis of C-ring modified triptolide analogues and their cytotoxic activities.
Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
Bioorg Med Chem Lett; 2006 Apr; 16(7):1947-9. PubMed ID: 16455242
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and anticancer activity evaluation of novel C14 heterocycle substituted epi-triptolide.
Xu H; Tang H; Feng H; Li Y
Eur J Med Chem; 2014 Feb; 73():46-55. PubMed ID: 24378709
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel triptolide analogues for anticancer activity.
Zhou B; Miao Z; Deng G; Ding J; Yang Y; Feng H; Li Y
Bioorg Med Chem Lett; 2010 Nov; 20(21):6217-21. PubMed ID: 20833543
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel C14-hydroxyl substituted triptolide derivatives as potential selective antitumor agents.
Li Z; Zhou ZL; Miao ZH; Lin LP; Feng HJ; Tong LJ; Ding J; Li YC
J Med Chem; 2009 Aug; 52(16):5115-23. PubMed ID: 19637874
[TBL] [Abstract][Full Text] [Related]
7. Semisynthesis of triptolide analogues: effect of B-ring substituents on cytotoxic activities.
Xu H; Chen Y; Tang H; Feng H; Li Y
Bioorg Med Chem Lett; 2014 Dec; 24(24):5671-5674. PubMed ID: 25467158
[TBL] [Abstract][Full Text] [Related]
8. Fluorination of triptolide and its analogues and their cytotoxicity.
Aoyagi Y; Hitotsuyanagi Y; Hasuda T; Matsuyama S; Fukaya H; Takeya K; Aiyama R; Matsuzaki T; Hashimoto S
Bioorg Med Chem Lett; 2008 Apr; 18(7):2459-63. PubMed ID: 18321701
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and structure-activity relationships studies on the D ring of the natural product triptolide.
Xu H; Tang H; Feng H; Li Y
ChemMedChem; 2014 Feb; 9(2):290-5. PubMed ID: 24339424
[TBL] [Abstract][Full Text] [Related]
10. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of cytotoxic effects of novel α-methylenelactone tetracyclic diterpenoids.
Zeng YF; Wu JQ; Shi LY; Wang K; Zhou B; Tang Y; Zhang DY; Wu YC; Hua WY; Wu XM
Bioorg Med Chem Lett; 2012 Mar; 22(5):1922-5. PubMed ID: 22318158
[TBL] [Abstract][Full Text] [Related]
12. Divergent total synthesis of triptolide, triptonide, tripdiolide, 16-hydroxytriptolide, and their analogues.
Xu H; Tang H; Feng H; Li Y
J Org Chem; 2014 Nov; 79(21):10110-22. PubMed ID: 25296383
[TBL] [Abstract][Full Text] [Related]
13. Semisynthesis and in vitro anticancer activities of andrographolide analogues.
Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J
Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property.
Wong KF; Chan JK; Chan KL; Tam P; Yang D; Fan ST; Luk JM
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):55-9. PubMed ID: 18047628
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives: Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl.
Xu F; Shi X; Li S; Cui J; Lu Z; Jin Y; Lin Y; Pang J; Pan J
Bioorg Med Chem; 2010 Mar; 18(5):1806-15. PubMed ID: 20149665
[TBL] [Abstract][Full Text] [Related]
16. [Progress in structure modification of triptolide].
Zhang F; Li YC
Yao Xue Xue Bao; 2004 Oct; 39(10):857-64. PubMed ID: 15700832
[No Abstract] [Full Text] [Related]
17. Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP
Song H; Xing W; Shi X; Zhang T; Lou H; Fan P
Bioorg Med Chem; 2021 Nov; 50():116466. PubMed ID: 34700239
[TBL] [Abstract][Full Text] [Related]
18. ATB
Lou D; Lou Z; Lin Y; Shangguan H; Lin Y; Luo Q; Zhang H; Lin G; Chen R; Kou L; Bao S
Bioorg Med Chem Lett; 2021 Feb; 33():127728. PubMed ID: 33346010
[TBL] [Abstract][Full Text] [Related]
19. Site-specific construction of triptolide-based antibody-drug conjugates.
Wei D; Mao Y; Xu Z; Chen J; Li J; Jiang B; Chen H
Bioorg Med Chem; 2021 Dec; 51():116497. PubMed ID: 34794002
[TBL] [Abstract][Full Text] [Related]
20. Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms.
Zhou ZL; Yang YX; Ding J; Li YC; Miao ZH
Nat Prod Rep; 2012 Apr; 29(4):457-75. PubMed ID: 22270059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
